Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease

ClinicalTrials.gov ID: NCT00090116

Public ClinicalTrials.gov record NCT00090116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 9, 2026, 8:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind,Placebo-Controlled Evaluation of the Safety and Efficacy of Neramexane Monotherapy in Patients With Moderate to Severe Dementia of the Alzheimer's Type

Study identification

NCT ID
NCT00090116
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

  • Neramexane Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2003
Primary completion
Feb 28, 2005
Completion
Feb 28, 2005
Last update posted
Mar 4, 2012

2003 – 2005

United States locations

U.S. sites
34
U.S. states
18
U.S. cities
33
Facility City State ZIP Site status
Pivotal Research Centers Peoria Arizona 85381
21st Century Neurology Phoenix Arizona 85013
Margolin Brain Institute Fresno California 93720
Pharmacology Research Institute Northridge California 91324
UCI Medical Center Orange California 92868
Pacific Research Network San Diego California 92103
Affiliated Research Institute San Diego California 92108
University of Colorado Health Sciences Center Denver Colorado 80262
Yale University School of Medicine New Haven Connecticut 06510
Baumel-Eisner Neuromedical Institute Fort Lauderdale Florida 33321
Berma Research Group Hialeah Florida 33016
Palm Beach Neurological Center Palm Beach Gardens Florida 33410
Neurology Clinical Research, Inc. Plantation Florida 33324
University of South Florida Tampa Florida 33612
Palm Beach Neurology West Palm Beach Florida 33407
Indiana Universisty Medical Center Indianapolis Indiana 46202
Lexington Clinic Lexington Kentucky 40504
J. Gary Booker, MD Shreveport Louisiana 71101
Mood and Memory Clinic of Michigan Farmington Hills Michigan 48334
St. Louis University St Louis Missouri 63104
Alzheimer's Research Corporation Lakehurst New Jersey 08733
Joel Ross, MD Long Branch New Jersey 07740
Ubhc/Umdnj Piscataway New Jersey 08855
Upstate Clinical Research Albany New York 12205
Nathan S. Kline Institute for Psychiatric Research Orangeburg New York 10962
Monroe Community Hospital Rochester New York 14620
Behavioral Medical Research of Saten Island, PC Staten Island New York 10305
Piedmont Medical Research Winston-Salem North Carolina 27103
Ohio State University Columbus Ohio 443210
Neurology and Neuroscience Center of Ohio Toledo Ohio 43623
Summit Research Network Portland Oregon 97223
Medical University of South Carolina Charleston South Carolina 29406
North Texas Neurology Research Wichita Texas 76301
Pioneer Pharmaceutical Research Midvale Utah 84047

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00090116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 4, 2012 · Synced May 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00090116 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →